Latest News
An interdisciplinary team of Harvard scientists has successfully reprogrammed cells in mice to reverse vision loss from glaucoma, as well as normal (not disease-related) vision loss associated with aging in mouse models.
BrightFocus Foundation today received the inaugural Impact Award from the Medical Technology Enterprise Consortium (MTEC) for its work supporting the scientific development of better treatments for repeated mild traumatic brain injury (mTBI). MTEC is a public-private partnership with the U.S. Department of Defense and key research, advocacy, and corporate organizations.
Press release on a new Alzheimer’s drug which shows promising results to slow disease progression.
MPTF (Motion Picture & Television Fund) and BrightFocus Foundation today announced a special Valentine’s virtual concert featuring acclaimed multi-hyphenate and Grammy-nominated vocalist Seth MacFarlane in support of the two nonprofits working together on research and care around Alzheimer’s disease.
Research suggests that changes to circulation and density of blood vessels in the eye may signal a risk of dementia and can be used as a screening tool for Alzheimer’s disease.
Three scientists – renowned for scientific breakthroughs in Alzheimer’s, macular degeneration and glaucoma and who were given key early support from BrightFocus – have been elected as members of the prestigious National Academy of Medicine.
BrightFocus Foundation, a premier source of private research funding to defeat Alzheimer’s disease, macular degeneration, and glaucoma, today announced the addition of Sharyn Rossi, PhD, to its senior staff as the organization’s new Director of Scientific Programs, Neuroscience.
The WHAM! (Women’s Health Access Matters!) Investigators Fund today announced $100,000 in support from BrightFocus Foundation for sex and gender-specific research to advance women’s brain health.
